Replies to post #38931 on RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

So looks like Varney co-founded Neurolixis with his friend Adrian Newman-Tancredi. Apparently they leased space at J+J's research facility, and have a 5HT-1a agonist program funded by MJFF. Hopefully Varney will find success and shake off the 'curse of the Ampakines'..



Concerning Neurolixis and Tancredi, Neuro commented last year --

>>> Adrian Newman-Tancredi is a real person, I've corresponded with him, and his path crossed Varney's at Servier, they are friends. He has a 5HT-1a agonist program funded by MJFF, which is obviously not Cortex-sourced. Indeed, Neurolixis' description of their interests has only minor overlap with Cortex's portfolio.

As to JNJ, JNJ has extra space at their LaJolla R&D site which they are renting to small companies, partly in the hope of building early-stage relationships that will give them a leg up when it comes to eventual partnering. But these are not partnerships, and they do not have any legal rights to IP or anything else coming out of these incubated firms. Newman-Tancredi probably needed a CA business registration to rent that space from JNJ, and thus needed a CA-domiciled registered agent. He knows Varney, may have needed input on establishing ties in the area, Varney was able to provide those. <<<